Search

Dr Lisa Hill, University of Birmingham - £244,249 

This project aims to develop a novel therapy for dry aged-related macular degeneration (AMD), delivered via an eye drop, which could reduce inflammation and restore cell health. The eye drop will include the recipe to make an important protein, known to be reduced in those with AMD. 

If you’re considering a gift in your Will to the Macular Society, thank you. Your gift will help beat macular disease for good.

There are many reasons why you might be considering a gift in your Will to the Macular Society.

We always recommend you use a solicitor to make your Will, to ensure that your final wishes are carried out just as you’d have wanted.

There are so many low vision aids (LVAs) on the market, making it difficult to know which one is right for you. But what really works? And which devices offer the best improvements to quality of life for those living with macular disease? 

Current treatments for wet age-related macular degeneration (AMD) have been life changing for many, helping to maintain vision. However, not all patients respond well to anti-VEGF injections, highlighting the need for alternative treatments. Professor Dulcie Mulholland and PhD student Elisha Griffin have been exploring whether 'homoisoflavonoids', found in rare hyacinth plants, could help prevent abnormal blood vessel growth in the macula.

Thank you so much for considering a gift in your Will to the Macular Society. By doing so, you are taking a precious step towards creating a future without macular disease.

We would like to thank all of the charitable trusts and foundations who have generously supported our vision to end macular disease. Macular disease is the biggest cause of sight loss in the UK and all our income is fundraised, so we are entirely reliant on donations from our kind supporters.